» Articles » PMID: 23677482

The Effects of Primary Care on Breast Cancer Mortality and Incidence Among Medicare Beneficiaries

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2013 May 17
PMID 23677482
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary care physician (PCP) services may have an impact on breast cancer mortality and incidence, possibly through greater use of screening mammography.

Methods: The authors conducted a retrospective, 1:1 matching case-control study using the Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database to examine use of PCP services and their association with breast cancer mortality and incidence. SEER cases representing the 3 outcomes of interest (breast cancer mortality, all-cause mortality among women diagnosed with breast cancer, and breast cancer incidence) were matched to unaffected controls from the 5% Medicare random sample. Conditional logistic regression was used to examine associations between physician visits and breast cancer outcomes while controlling for other covariates.

Results: Women who had 2 or more PCP visits during the 24-month assessment interval had lower odds of breast cancer mortality, all-cause mortality, and late-stage breast cancer diagnosis compared with women who had no PCP visits or 1 PCP visit while adjusting for other covariates, including mammography and non-PCP visits. Women who had 5 to 10 PCP visits had 0.69 times the odds of breast cancer mortality (95% confidence interval, 0.63-0.75), 0.83 times the odds of death from any cause having been diagnosed with breast cancer (95% confidence interval, 0.79-0.87), and 0.67 times the odds of a late-stage breast cancer diagnosis (95% confidence interval, 0.61-0.73) compared with those who had no PCP visits or 1 PCP visit.

Conclusions: The current findings suggest that PCPs play an important role in reducing breast cancer mortality among the Medicare population. Further research is needed to better understand the impact of primary care on breast cancer and other cancers that are amendable to prevention or early detection.

Citing Articles

Effects of Medicaid managed care on early detection of cancer: Evidence from mandatory Medicaid managed care program in Pennsylvania.

Kwon Y, Roberts E, Cole E, Degenholtz H, Jacobs B, Sabik L Health Serv Res. 2024; 59(5):e14348.

PMID: 38958003 PMC: 11366964. DOI: 10.1111/1475-6773.14348.


Patient and provider-level drivers of healthcare utilization related to a diagnosis of a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS).

Castaneda-Avila M, Mazor K, Lapane K, Epstein M Cancer Causes Control. 2023; 34(5):449-457.

PMID: 36853428 DOI: 10.1007/s10552-023-01675-1.


Clinical Multiteam System Composition and Complexity Among Newly Diagnosed Early-Stage Breast, Colorectal, and Lung Cancer Patients With Multiple Chronic Conditions: A SEER-Medicare Analysis.

Doose M, Verhoeven D, Sanchez J, McGee-Avila J, Chollette V, Weaver S JCO Oncol Pract. 2022; 19(1):e33-e42.

PMID: 36473151 PMC: 10166428. DOI: 10.1200/OP.22.00304.


Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance.

Castaneda-Avila M, Lapane K, Person S, Jesdale B, Zhou Y, Mazor K Cancer Control. 2022; 29:10732748221126936.

PMID: 36112886 PMC: 9478713. DOI: 10.1177/10732748221126936.


What is a Primary Care Doctor's Work Worth?.

Schiel K Mo Med. 2022; 119(3):206-207.

PMID: 36035571 PMC: 9324727.


References
1.
Iglehart J . Primary care update--light at the end of the tunnel?. N Engl J Med. 2012; 366(23):2144-6. DOI: 10.1056/NEJMp1205537. View

2.
Roetzheim R, M Ferrante J, Lee J, Chen R, Love-Jackson K, Gonzalez E . Influence of primary care on breast cancer outcomes among Medicare beneficiaries. Ann Fam Med. 2012; 10(5):401-11. PMC: 3438207. DOI: 10.1370/afm.1398. View

3.
Fox S, Siu A, Stein J . The importance of physician communication on breast cancer screening of older women. Arch Intern Med. 1994; 154(18):2058-68. View

4.
Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

5.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View